Liothyronine (L-T3) and Levothyroxine (L-T4)
For information about L-T3 therapy, please see this page
News Archive
Graves' Disease Drug Trial
A new drug is being assessed at UK hospital sites for the treatment of Graves' disease. For more details of the trial and to see if you are eligible to participate please see our trials and surveys page.
Results from the Newcastle 85+ Study
Putting thyroid tests into context: results from the Newcastle 85+ study
Professor Simon Pearce, Professor of Endocrinology, Institute of Genetic Medicine, Newcastle upon Tyne, outlines the results of a study he has been involved in that indicates there is no good reason to treat older people with slightly elevated TSH levels provided they are feeling OK. Read the full article here.
Milton Keynes Yoga and Nutrition Day
Tickets are now available for the Milton Keynes local group's Yoga and Nutrition Day on Saturday November 12th 2016 at 10:15am to 12:45pm
Re-introduction of Teva levothyroxine tablets to the UK market: new strengths and lactose free
The UK Government has lifted restrictions on Teva levothyroxinie tablets following the introduction of new strengths. They are also lactose free. For more information visit the Medicines and Healthcare products Regulatory Agency news release.
